Remicade (infliximab), a new biotech drug for Crohn's disease

October 1998

Centocor will market Remicade (infliximab), a new biotech drug for Crohn's disease.

It's a monoclonal antibody that neutralizes the activity of tumor necrosis factor...a protein that promotes inflammation.

Remicade is also being tested for other inflammatory conditions such as rheumatoid arthritis.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

lots of attention now on sports supplements
Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis
Diabetes intensive treatment of type 2 diabetes reduces complications
Infectious Diseases Cipro suspension
Infectious Diseases RotaShield, the first vaccine to prevent rotavirus infection in infants and young children
there's NO need to stop warfarin therapy before most dental surgery
lots of ads for new dental chewing gums
surprising link between chronic gum infection and other conditions
Gastroenterology Remicade (infliximab), a new biotech drug for Crohn's disease
Hematology & Oncology two significant new approaches for treating and preventing breast cancer
Hematology & Oncology Tamoxifen (Nolvadex) will be approved to PREVENT breast cancer
Hematology & Oncology selenium lowers the risk of prostate cancer
Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day
Women's Health calcium supplements can help relieve premenstrual syndrome (PMS)
Women's Health Preven Emergency Contraceptive Kit
Women's Health Some Washington pharmacists now provide emergency contraceptive pills (ECPs) to women
new precaution in the package insert of inhaled corticosteroids